Yehoda M Martei, MD, MSCE

Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
3400 Civic Center Blvd.
Philadelphia, PA 19104
Philadelphia, PA 19104
Publications
Education:
BA (Biology)
Harvard University, 2005.
MD (Medicine)
Yale University School of Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2018.
Permanent linkBA (Biology)
Harvard University, 2005.
MD (Medicine)
Yale University School of Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2018.
Selected Publications
Kizub DA, Naik S, Abogan AA, Pain D, Sammut S, Shulman LN, Martei YM.: Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda. Oncologist 27(11): 958-970, Nov 2023 Notes: DOI: 10.1093/oncolo/oyac143Motlokwa PK, Tsima BM, Martei YM, Ralefala T, Galebole F, Stephens-Shields AJ, Grover S, Gross R.: Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa. JCO Glob Oncol 8: e2100439, Aug 2022 Notes: DOI: 10.1200/GO.21.00439
Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, Gross R, Shulman LN, Grover S, DeMichele A.: Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy. JCO Glob Oncol 8: e2200016. May 2022 Notes: DOI: 10.1200/GO.22.00016
Martei YM, Grover S, Narasimhamurthy M, Setlhako DI, Ayane GN, Ralefala TB, Chiyapo SP, Gross R, DeMichele A, Shulman LN : Relative dose intensity and pathologic response rates in HIV-infected and HIV-uninfected breast cancer patients who received neoadjuvant chemotherapy. Journal of Clinical Oncology 18(15 Suppl e19140): e2200016, May 2022.
Martei YM, Clark AS.: Navigating Systemic Therapeutic Options for First-Line Metastatic Hormone Receptor-Positive, ERBB2-Negative Breast Cancer Treatment. JAMA Netw Open 5: e224380, Apr 2022.
Martei YM, Dauda B, Vanderpuye V.: Correction: Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer 22(1): 306, Mar 2022.
Razis E, Kassapian M, Andriakopoulou C, Martei YM, Zurn SJ, Hammad N, Romero Y, Dafni U, Ilbawi AM, Trapani D.: Essential medicines list in national cancer control plans: a secondary analysis from a global study. Lancet Oncol 23(3): e144-154, Mar 2022.
Martei YM, Dauda B, Vanderpuye V.: Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer 22: 203, Feb 2022.
Ralefala T, Mokokwe L, Jammalamadugu S, Legobere D, Motlhwa WS, Oyekunle AA, Grover S, Barg FK, Shulman LN, Martei YM: Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis. Oncologist 26(12): e2200-e2208, Dec 2021.
Davey S, Grover S, Bilker WB, Setlhako DI, Ralefala TB, Manshimba P, Gross R, DeMichele A, Shulman LN, Martei YM.: Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana. BMJ Open 11(7): e049574, Jul 2021.